Check out our most popular compounded medications! Get Started
Dihydroergotamine Mesylate 0.15% Nasal Spray is a prescription liquid formulation, administered via a nasal spray. It is specifically designed for targeted local or systemic effects through the nostrils. This medication is used to treat conditions such as migraine, cluster headache, Meniere's disease, tension headache, and sinusitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dihydroergotamine Mesylate 0.15% Nasal Spray is a specially compounded prescription medication designed to alleviate the symptoms of migraine and cluster headaches. This liquid formulation is delivered in a spray form, specifically designed for administration into the nasal cavity. It works by constricting the blood vessels around the brain, thereby reducing the pain associated with these types of headaches.
The medication is administered by spraying a single dose into each nostril, providing targeted local or systemic effects through the nostrils.
Common side effects can include nasal irritation, nasal congestion, and a bitter taste in the mouth. However, it's crucial to note that this medication is not suitable for everyone. Individuals with certain medical conditions, such as uncontrolled high blood pressure, heart disease, or a history of stroke, should not use this medication.
If you have any questions or concerns about Dihydroergotamine Mesylate 0.15% Nasal Spray, please do not hesitate to contact us at Bayview Pharmacy.
Dihydroergotamine Mesylate 0.15% Nasal Spray is a liquid formulation specifically designed for administration into the nasal cavity. It is indicated for the acute treatment of migraine headaches with or without aura, as well as cluster headaches in adults. This formulation is not intended for the prevention or reduction of the frequency of these headaches.
Patients are advised to use the nasal spray as soon as possible after the onset of a migraine or cluster headache. The recommended dose is one spray in one nostril, with a maximum of two sprays in one nostril per 24 hours. It is important not to exceed this dosage.
While using Dihydroergotamine Mesylate 0.15% Nasal Spray, patients should avoid using other medications to treat their migraine or cluster headache. This includes over-the-counter medications such as ibuprofen, acetaminophen, and aspirin.
Alcohol consumption should be avoided while using this nasal spray, as it can increase the risk of side effects such as dizziness, drowsiness, and nausea. Similarly, patients should avoid driving or operating heavy machinery while using this medication due to potential side effects like dizziness, drowsiness, and blurred vision.
Patients should also avoid taking other medications that contain ergotamine or ergot alkaloids while using Dihydroergotamine Mesylate 0.15% Nasal Spray. This includes medications such as ergotamine tartrate, dihydroergotamine mesylate, and methysergide maleate.
It is important for patients to inform their healthcare provider if they are pregnant, planning to become pregnant, or breastfeeding before using Dihydroergotamine Mesylate 0.15% Nasal Spray. If you have any questions about using this medication, please reach out to your healthcare provider.
Dihydroergotamine Mesylate 0.15% Nasal Spray is a specialized prescription medication, primarily used in the treatment of migraine and cluster headaches. This medication functions by constricting the blood vessels in the brain, which in turn reduces the inflammation and pain associated with these types of headaches. Additionally, it aids in decreasing the frequency of migraine attacks.
The nasal spray is designed for administration into the nasal cavity, providing targeted local or systemic effects through the nostrils. The typical dosage involves spraying one or two doses into each nostril, usually once or twice a day. It is crucial to adhere to the prescribed dosage and frequency as directed by your healthcare provider. Overuse or misuse of the medication can lead to unwanted side effects or reduced effectiveness.
When using Dihydroergotamine Mesylate 0.15% Nasal Spray, it is essential to follow all instructions provided by your healthcare provider. It is equally important to inform your doctor about any other medications you are currently taking, as there may be potential interactions with Dihydroergotamine Mesylate 0.15% Nasal Spray.
Common side effects of this medication include nausea, vomiting, dizziness, and drowsiness. If you experience any of these side effects, it is recommended to contact your healthcare provider immediately. Always remember that your healthcare provider has prescribed this medication because they have judged that the benefit to you is greater than the risk of side effects.
If you have any questions or concerns about Dihydroergotamine Mesylate 0.15% Nasal Spray or its mechanism of action, please do not hesitate to reach out to us at Bayview Pharmacy. Our team is dedicated to helping you understand your medication and ensuring you achieve the best possible results from your treatment.
Dihydroergotamine Mesylate 0.15% Nasal Spray is a liquid formulation delivered in a spray form, specifically designed for administration into the nasal cavity. It provides targeted local or systemic effects through the nostrils.
This nasal spray works by delivering the medication directly into the nasal cavity, allowing for targeted local or systemic effects. The active ingredient, Dihydroergotamine Mesylate, works to alleviate symptoms associated with certain conditions.
You should use this nasal spray as directed by your healthcare provider. It is typically administered into the nostrils.
As with any medication, there may be potential side effects. It's important to discuss these potential side effects with your healthcare provider before starting this medication.
Before using this medication, you should discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
Before starting this medication, you should discuss with your healthcare provider about any other medications you are currently taking to avoid potential drug interactions.
If you miss a dose, you should take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
You should store this medication in a cool, dry place away from light and out of reach of children. Do not freeze the medication and avoid extreme heat or cold.
If you suspect an overdose, seek immediate medical attention or call your local poison control center.
No, you should not share your medication with others. This medication is prescribed for your specific condition and may not be suitable for others.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale intranasally
